Navigation Links
AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
Date:5/5/2009

REDWOOD CITY, Calif., May 5 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. today announced that it has initiated a Phase 2 clinical trial of its ARX-01 Sufentanil NanoTab(TM) PCA System, a proprietary drug/device combination product candidate being developed for management of acute post-operative pain in the hospital setting. The primary objective of this open-label study is to assess the functionality of the ARX-01 System for post-operative pain management in patients undergoing unilateral knee replacement surgery.

AcelRx Chief Executive Officer, Thomas Schreck, commented, "We have successfully completed two placebo-controlled Phase 2 studies evaluating the efficacy and safety of Sufentanil NanoTabs in knee replacement and major abdominal surgery patients. Now with this third Phase 2 study we are validating the functionality of the handheld component of the ARX-01 Sufentanil NanoTab PCA System as we advance the ARX-01 clinical program."

Study investigator David Griffin, MD, of the Orthopaedic Center of Vero Beach, Florida stated, "I am excited about ARX-01; I believe it has the potential to address a large unmet medical need in the management of post-operative pain by allowing patients to manage their pain without the need for an IV line or complicated IV PCA pumps. Seeing the smooth, uneventful initiation of this first study utilizing the ARX-01 Sufentanil PCA System adds to the already compelling Phase 2 data that AcelRx announced in December."

About Acute Post-Operative Pain

Annually, approximately 8 million patients in the U.S. receive intravenous (IV) patient-controlled analgesia (PCA), typically utilizing morphine, for inpatient post-operative pain, with a similar number in the E.U. Despite its widespread use, the IV PCA architecture has several limitations. The IV line tethering the patient to the PCA pump discourages mobility, which is a critical factor in preventing post-operative c
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
2. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
5. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
6. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
7. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
8. Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes
9. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
10. Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
11. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014 A pharmaceutical executive in ... with three issues he wanted the research and consulting ... external personnel (especially for secondary research) to maximize efficiency ... of increased workload , Automation of market research ... , How to implement and manage those automated ...
(Date:9/19/2014)... /PRNewswire-iReach/ -- Market Research Report on Global ... a professional and in-depth market survey on ... report firstly reviews the basic information of ... manufacturing technology. The report then explores global ... listing their product specification, capacity, Production value, ...
(Date:9/19/2014)... Kiromic, LLC, a Lubbock bio-pharmaceutical company, ... former chancellor of Texas Tech University, to its board as ... after raising $1.2 billion for the university. "Kiromic ... most successful chancellor in the history of Texas Tech University, ... but also as our new vice chairman of the board. ...
Breaking Medicine Technology:In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2
(Date:9/20/2014)... The festival season is coming soon. The high-end fashion designer ... cocktail dresses . A lot of sophisticated women like its ... new promotion for its high quality clothes. Now, each of ... 20 to 71 percent off. , The company’s cocktail ... provided in many fashionable colors. Mary, the company’s sales manager, ...
(Date:9/20/2014)... September 20, 2014 New PharmaPoint ... Market Analysis to 2023?. The asthma market saw ... it has become saturated with relatively efficacious standard ... (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), and ... generic competition. However, the launch of seven novel ...
(Date:9/20/2014)... 20, 2014 iFitDress.com, the popular online ... women, has recently unveiled its new collection of cocktail ... for special offer on these new outfits; it intends ... All customers can now buy cheap cocktail dresses ... sales representative says, “We have extensive experience in the ...
(Date:9/20/2014)... 2014 The excitement is building up once again ... Carolina. This year the Surry Arts Council will be celebrating ... the country who are still fans of the Andy Griffith Show. ... that aired on CBS from 1960 through 1968. The show ... television history. Mount Airy, North Carolina is where the show ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 "As a nurse, ... their tanks," said an inventor from Tamaqua, Pa. "The reason ... on the backs of their chairs. My invention enables them ... the Kam Oxygen Sensor to make it easier to monitor ... the user knows when the tank is low. It allows ...
Breaking Medicine News(10 mins):Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2
... imaging developed by researchers at Duke University,s Pratt School ... better than those made with traditional ultrasound, according to ... suggests that the imaging method known as Acoustic Radiation ... for screening patients at increased risk for liver cancers, ...
... Cardiovascular problems surfaced in people with no history of ... People with no history of heart problems who felt ... to heart problems in the three years following the ... trigger an immediate lethal heart attack in some people, ...
... Wellness Solutions DVD Series Offer Integrative Health ... Solutions for Ten Chronic Medical Conditions, BROOMFIELD, Colo., Jan. ... with more than 46,percent of the fitness and wellness market, ... of DVDs focused on providing,integrative health solutions for ten chronic ...
... SAN DIEGO, Jan. 7 Calorie-conscious, health-minded,Americans ... new ally to support them in following,through ... nutrition information about healthier choices at a ... restaurants from fast food to,upscale dining establishments ...
... / Cariani /,Lindsay, a leading, national executive and board ... Partner. She will be based in the,Firm,s Los Angeles ... sectors., Prior to joining HNCL Search, Vicky was ... Before Warner Bros., she,spent six years at Heidrick & ...
... The Columbia Center for Childrens Environmental Health (CCCEH) ... has received a $10.4 million grant from the ... study environmental contributors to childhood asthma. The ... called Disease Investigation through Specialized Clinically-Oriented Ventures in ...
Cached Medicine News:Health News:High-energy ultrasound sharpens view of liver tumors 2Health News:High Levels of Stress After 9/11 Raised Heart Disease Risk 2Health News:High Levels of Stress After 9/11 Raised Heart Disease Risk 3Health News:Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic 2Health News:Gaiam Inc., The Leader in Innovative Lifestyle Solutions, Announces New DVD Series Created with Mayo Clinic 3Health News:Online Resource Keeps Restaurant Diners on Track After New Year's Hype Subsides 2Health News:Vicky Goldberg Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay 2Health News:Columbia Center for Children's Environmental Health receives NIEHS grant to study asthma 2Health News:Columbia Center for Children's Environmental Health receives NIEHS grant to study asthma 3Health News:Columbia Center for Children's Environmental Health receives NIEHS grant to study asthma 4
... ThinProfile™ Eyelid Implants, available from FCI ... the original FCI Contour™ Eyelid Implants, ... tapered edges and smoothly rounded corners. ... added freedom in suturing position. The ...
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
For Frontalis Suspension in patients with significant ptosis and poor levator function....
Medicine Products: